Personalized Medicine
ISSN:1741-0541

Personalized Medicine

PERS MED
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:较慢,6-12周
新锐分区:医学4区
年发文量:33
影响因子:1.8
JCR分区:Q3

基本信息

个性化 医学 ( ISSN1741 - 0541 ) 将 最近 的 基因 组 学 、 遗传 学 和 蛋白 质 组 学 进展 转化 为 临床 背景 。该 杂志 为 所有 参与 者 提供 了 一 个 综合 论坛 - 学术 和 临床 研究 人员 、 制药 公司 、 监管 机构 、 医疗 保健 管理 组织 、 患者 组织 和 医疗 保健 界 的 其他 人 。个性化 医学 通过 提供 一 个 专家 评论 和 分析 的 平台 , 帮助 这些 团体 塑造 医学 的 未来 。 该 杂志 致力 于 精准 医学 领域 的 科学 、 商业 和 政策 问题 , 包括 新闻 和 观点 、 新 生物 标志 物 的 最 新 认识 、 简明 的 评论 和 分析 、 来自 会议 巡回 的 报告 和 完整 的 评论 文章 。
1741-0541SCIE/Scopus收录
1.8
1.1
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q3
244/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:PHARMACOLOGY & PHARMACY
SCIE
Q3
251/353
24
33
13%0较慢,6-12周-医学-药学
0%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
75.76%11.11%2.7%
CiteScore:3.20
SJR:0.459
SNIP:0.344
学科类别分区排名百分位
大类:Medicine
小类:General Medicine
Q2
172 / 668
大类:Medicine
小类:Pharmacology
Q3
203 / 321
大类:Medicine
小类:Molecular Medicine
Q4
135 / 177

期刊高被引文献

Continuing war on pain: a personalized approach to the therapy with nonsteroidal anti-inflammatory drugs and opioids.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0116
From helices to health: undergraduate medical education in genetics and genomics.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0081
Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer.
来源期刊:Personalized medicineDOI:10.2217/pme-2016-0058
Preparing next-generation scientists for biomedical big data: artificial intelligence approaches.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0145
The clinical application of gene editing: ethical and social issues.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0155
Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0076
Precision medicine: a call for increased pharmacogenomic education.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0107
Preventive effects of oxytocin and oxytocin receptor in breast cancer pathogenesis.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0009
Provider engagement in precision oncology education: an exploratory analysis of online continuing medical education data.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0150
The association study of CLOCK gene polymorphisms with antidepressant effect in Chinese with major depressive disorder.
来源期刊:Personalized medicineDOI:10.2217/PME-2018-0123
Lipoprotein(a) as a marker for predicting coronary collateral circulation in patients with acute myocardial infarction.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0127
Current applications of precision medicine: a bibliometric analysis.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0089
Survivin c.-31G>C (rs9904341) gene transversion and urinary system cancers risk: a systematic review and a meta-analysis.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0053
Efficacy and safety of direct-acting antivirals for treatment-naive patients with genotype 1 hepatitis C virus infection.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0121
Protein inhibitor of activated STAT genes are differentially expressed in breast tumor tissues.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0070
MTHFR polymorphisms as risk for male infertility in Pakistan and its comparison with socioeconomic status in the world.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0045
Potential regulatory SNPs in the ATXN7L3B and KRT15 genes are associated with gender-specific colorectal cancer risk.
来源期刊:Personalized medicineDOI:10.2217/pme-2019-0059
The effect of CYP2C19 genotype-guided antiplatelet therapy on outcomes of selective percutaneous coronary intervention patients: an observational study.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0087
Association between expression of long noncoding RNAs in placenta and pregnancy features.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0078
Cytochrome 2C19 and paraoxonase-1 polymorphisms and clopidogrel resistance in ischemic heart disease patients.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0030
Clinical and research applications of a brain tumor tissue bank in the age of precision medicine
来源期刊:Personalized MedicineDOI:10.2217/pme-2018-0102
Cost-effectiveness of BRCA1/2 mutation profiling to target olaparib use in patients with metastatic breast cancer.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0141
Metabolomic diagnostics and human digital image.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0066
The public perception of the facilitators and barriers to implementing personalized medicine: a systematic review.
来源期刊:Personalized medicineDOI:10.2217/PME-2018-0151
Biobanking as a necessary tool for research in the field of personalized medicine in the scientific medical center.
来源期刊:Personalized medicineDOI:10.2217/pme-2019-0049
Functional polymorphism within miR-23a∼27a∼24-2 cluster confers clinical outcome of breast cancer in Pakistani cohort.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0059
Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0077
Individualized medication of digoxin based on the serum drug concentration and blood biochemical indexes.
来源期刊:Personalized medicineDOI:10.2217/pme-2019-0006
Association of CYP2C19 and UGT1A4 polymorphisms with voriconazole-induced liver injury.
来源期刊:Personalized medicineDOI:10.2217/pme-2019-0042
Implementing universal cancer screening programs can help sustain genomic medicine programs.
来源期刊:Personalized medicineDOI:10.2217/pme-2019-0126
Association of maternal xenobiotic-metabolizing gene polymorphisms with risk of fetal growth restriction.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0125
Association between functional polymorphisms in the promoter of the miR-143/145 cluster and risk of conotruncal heart defects.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0154
How can the personal discovery process evolve personalized medicine? An interview with Laura Towart.
来源期刊:Personalized MedicineDOI:10.2217/PME-2019-0087
Using clinical genomic sequencing to guide personalized cancer therapy in China.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0056
Exploring professional issues: the psychosocial component of genetic counseling in genomic healthcare.
来源期刊:Personalized medicineDOI:10.2217/pme-2019-0048
Application of the genetic risk model for the analysis of predisposition to nonlacunar ischemic stroke.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0104
Antithrombotic therapy in acute coronary syndrome and stable coronary artery disease patients with atrial fibrillation: a 3-year retrospective cohort study.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0092
Dexmedetomidine improves neurodevelopment and cognitive impairment in infants with congenital heart disease.
来源期刊:Personalized medicineDOI:10.2217/pme-2019-0003
Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemia.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0135
Weight-related genomic information and provider communication approach: looking through the lens of patient race.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0148
Screening of NogoA/NTR-related differential genes in rat sciatic nerve injury signal pathway.
来源期刊:Personalized medicineDOI:10.2217/pme-2018-0088

相关文章

2026年3月发布
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
4区